Rijkers, G.T.; Weterings, N.; Obregon-Henao, A.; Lepolder, M.; Dutt, T.S.; van Overveld, F.J.; Henao-Tamayo, M.
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines 2021, 9, 848.
https://doi.org/10.3390/vaccines9080848
AMA Style
Rijkers GT, Weterings N, Obregon-Henao A, Lepolder M, Dutt TS, van Overveld FJ, Henao-Tamayo M.
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines. 2021; 9(8):848.
https://doi.org/10.3390/vaccines9080848
Chicago/Turabian Style
Rijkers, Ger T., Nynke Weterings, Andres Obregon-Henao, Michaëla Lepolder, Taru S. Dutt, Frans J. van Overveld, and Marcela Henao-Tamayo.
2021. "Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines" Vaccines 9, no. 8: 848.
https://doi.org/10.3390/vaccines9080848
APA Style
Rijkers, G. T., Weterings, N., Obregon-Henao, A., Lepolder, M., Dutt, T. S., van Overveld, F. J., & Henao-Tamayo, M.
(2021). Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines, 9(8), 848.
https://doi.org/10.3390/vaccines9080848